Bromide

Bromide

SCHEMBL1132963

Br.CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.[N-]=[N+]=[N-]

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 7/20 0.90
BCHE P06276 4/20 0.90
MEN1 O00255 4/20 0.90
BLM P54132 4/20 0.90
KMT2A Q03164 4/20 0.90
KDM4E B2RXH2 3/20 0.90
CYP3A4 P08684 3/20 0.90
MAPT P10636 3/20 0.90
THRB P10828 3/20 0.90
HPGD P15428 3/20 0.90
CASP1 P29466 3/20 0.90
RECQL P46063 3/20 0.90
CASP7 P55210 3/20 0.90
CYP1A2 P05177 1/20 0.90
CYP2D6 P10635 1/20 0.90
CYP2C9 P11712 1/20 0.90
CYP2C19 P33261 1/20 0.90
TERT O14746 3/20 0.60
MITF O75030 2/20 0.60
NSD2 O96028 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3629831 0.99 ACHE (0.92) ACHEBCHEMEN1BLMKMT2A
SCHEMBL16912939 0.99 ACHE (0.92) ACHEBCHEMEN1BLMKMT2A
SCHEMBL30379131 0.95 ACHE (1.00) ACHEBCHEMEN1BLMKMT2A
SCHEMBL55279 0.95 ACHE (1.00) ACHEBCHEMEN1BLMKMT2A
Hydrochloric Acid SCHEMBL5482694 0.94 ACHE (0.98) ACHEBCHEMEN1BLMKMT2A
Iodide SCHEMBL14996 0.94 ACHE (1.00) ACHEBCHEMEN1BLMKMT2A
SCHEMBL16331307 0.94 ACHE (0.98) ACHEBCHEMEN1BLMKMT2A
Bromide SCHEMBL30669741 0.94 ACHE (0.98) ACHEBCHEMEN1BLMKMT2A
Iodide SCHEMBL29351886 0.94 ACHE (1.00) ACHEBCHEMEN1BLMKMT2A
Iodide SCHEMBL29527724 0.94 ACHE (1.00) ACHEBCHEMEN1BLMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964790-B1 SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS LITRON LABORATORIES LTD (US) 2023-06-07 EP claimed
US-20180100851-A1 SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS LITRON LABORATORIES LTD (US) 2018-04-12 US claimed
US-20170003276-A1 SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS LITRON LABORATORIES LTD (US) 2017-01-05 US claimed
US-9470694-B2 Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations LITRON LABORATORIES LTD. (US) 2016-10-18 US claimed
EP-2964790-A1 SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS Litron Laboratories, Ltd (US) 2016-01-13 EP claimed
WO-2014164312-A1 SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS LITRON LABORATORIES, LTD (US) 2014-10-09 WO claimed
US-20140255948-A1 SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS LITRON LABORATORIES, LTD. (US) 2014-09-11 US claimed
US-20140017673-A1 METHOD FOR ENUMERATING EUKARYOTIC CELL MICRONUCLEI WITH AN EMPHASIS ON SIMULTANEOUSLY ACQUIRING CYTOTOXICITY AND MODE OF ACTION INFORMATION LITRON LABORATORIES, LTD. (US) 2014-01-16 US claimed
US-11828763-B2 Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations LITRON LABORATORIES, LTD. (US) 2023-11-28 US disclosed
EP-2964790-B1 SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS LITRON LABORATORIES LTD (US) 2023-06-07 EP disclosed
US-11016101-B2 Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations LITRON LABORATORIES LTD. (US) 2021-05-25 US disclosed
US-20210132081-A1 SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS LITRON LABORATORIES LTD (US) 2021-05-06 US disclosed
CN-112566649-A Microbiota Restoration Therapy (MRT) compositions and methods of manufacture 雷柏奥提斯有限公司 2021-03-26 CN disclosed
US-10802013-B2 Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations LITRON LABORATORIES LTD. (US) 2020-10-13 US disclosed
WO-2014164312-A1 SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS LITRON LABORATORIES, LTD (US) 2014-10-09 WO disclosed
US-20140255948-A1 SIMPLIFIED NUCLEI ANALYSIS PLATFORM AND BIOMARKER MATRIX THAT SUPPORTS GENOTOXIC MODE OF ACTION DETERMINATIONS LITRON LABORATORIES, LTD. (US) 2014-09-11 US disclosed
US-20140017673-A1 METHOD FOR ENUMERATING EUKARYOTIC CELL MICRONUCLEI WITH AN EMPHASIS ON SIMULTANEOUSLY ACQUIRING CYTOTOXICITY AND MODE OF ACTION INFORMATION LITRON LABORATORIES, LTD. (US) 2014-01-16 US disclosed
US-20120190028-A1 NUCLEIC ACIDS AND METHODS FOR THE DETECTION OF ENTEROBACTER SAKAZAKII (CRONOBACTER SPP.) BIOTECON DIAGNOSTICS GMBH (DE) 2012-07-26 US disclosed
EP-2287333-A1 Nucleic acids and methods for the detection of enterobacter sakazakii (cronobacter spp.) Biotecon Diagnostics GmbH (DE) 2011-02-23 EP disclosed
WO-2011015356-A1 NUCLEIC ACIDS AND METHODS FOR THE DETECTION OF ENTEROBACTER SAKAZAKII (CRONOBACTER SPP.) BIOTECON DIAGNOSTICS GMBH (DE) 2011-02-10 WO disclosed